& quot; It may begin to be tested in humans & quot;: new advances in the Argentine coronavirus vaccine

The Ministry of Science, Technology and Innovation confirmed that the first phase of trials of the vaccine Argentina against the coronavirus will begin in January of next year. Meanwhile, large-scale production could start in late 2022 or early 2023.

The vaccine, named “ARVAC-Cecilia Grierson” in honor of the country’s first doctor, will have completed preclinical studies by the end of this year, in the words of Daniel Filmus. To be effective against the virus, the dose It is in the final stages of toxicity testing.

Leave a Comment